ALLOX
Barcelona, Spain
◆ Total Raised
$10.5M
◆ Stage
seed
◆ Location
Barcelona, Spain
◆ Founded
2023
◆ Team size
11-50
◆ Links
◆ About ALLOX
Biotechnology company developing a drug discovery platform combining high-throughput genetics, experimental biology and artificial intelligence to identify therapeutic opportunities for small-molecule therapeutics.
◆ What sets it apart
ALLOX directly measures the functional effects of thousands of mutations and combines those data with AI to reveal actionable allosteric and regulatory sites that conventional structure-based discovery can miss.[1][2]
◆ Sectors
◆ Business
Modeltransactional
CustomerPharmaceutical and biotechnology companies seeking novel drug targets, protein-interaction opportunities, and small-molecule therapeutics
◆ Notable
- Founded as a spin-off of the Centre for Genomic Regulation in Barcelona
- Established at the Barcelona Science Park
- Closed a $10.5 million seed financing round led by Asabys, with participation from CDTI and ICF[1][2]
◆ Backing funds on Raise
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does ALLOX do?
Biotechnology company developing a drug discovery platform combining high-throughput genetics, experimental biology and artificial intelligence to identify therapeutic opportunities for small-molecule therapeutics.
Where is ALLOX based?
ALLOX is based in Barcelona, Spain, founded in 2023.
How much has ALLOX raised?
ALLOX has raised $10.5M in tracked funding and is currently at the seed stage.
Who has invested in ALLOX?
Investors in ALLOX include Asabys Partners, CDTI Innovation and Institut Català de Finances.